Anti-complement C1s antibodies
First Claim
Patent Images
1. A humanized antibody that binds complement C1s protein and comprises:
- a light chain variable region that comprises a CDR-L1 amino acid sequence set forth in SEQ ID NO;
1, a CDR-L2 amino acid sequence set forth in SEQ ID NO;
2, and a CDR-L3 amino acid sequence set forth in SEQ ID NO;
3;
a heavy chain variable region that comprises a CDR-H1 amino acid sequence set forth in SEQ ID NO;
4, a CDR-H2 amino acid sequence set forth in SEQ ID NO;
5, and a CDR-H3 amino acid sequence set forth in SEQ ID NO;
6; and
an IgG4 constant region comprising an S241P substitution (by Kabat numbering) and an L235E substitution (by EU numbering).
2 Assignments
0 Petitions
Accused Products
Abstract
The present disclosure provides antibodies that bind complement C1s protein; and nucleic acid molecules that encode such antibodies. The present disclosure also provides compositions comprising such antibodies, and methods to produce and use such antibodies, nucleic acid molecules, and compositions.
-
Citations
9 Claims
-
1. A humanized antibody that binds complement C1s protein and comprises:
-
a light chain variable region that comprises a CDR-L1 amino acid sequence set forth in SEQ ID NO;
1, a CDR-L2 amino acid sequence set forth in SEQ ID NO;
2, and a CDR-L3 amino acid sequence set forth in SEQ ID NO;
3;a heavy chain variable region that comprises a CDR-H1 amino acid sequence set forth in SEQ ID NO;
4, a CDR-H2 amino acid sequence set forth in SEQ ID NO;
5, and a CDR-H3 amino acid sequence set forth in SEQ ID NO;
6; andan IgG4 constant region comprising an S241P substitution (by Kabat numbering) and an L235E substitution (by EU numbering). - View Dependent Claims (2)
-
-
3. A humanized antibody that binds complement C1s protein and comprises:
-
a CDR-L1 sequence, a CDR-L2 sequence, and a CDR-L3 sequence of an antibody light chain variable region that comprises the amino acid sequence set forth in SEQ ID NO;
44;a CDR-H1 sequence, a CDR-H2 sequence, and a CDR-H3 sequence of an antibody heavy chain variable region that comprises the amino acid sequence set forth in SEQ ID NO;
42; andan IgG4 constant region comprising an S241P substitution (by Kabat numbering) and an L235E substitution (by EU numbering). - View Dependent Claims (4)
-
-
5. A humanized antibody that binds complement C1s protein and comprises:
-
an antibody light chain variable region that comprises the amino acid sequence set forth in SEQ ID NO;
44;an antibody heavy chain variable region that comprises the amino acid sequence set forth in SEQ ID NO;
42; andan IgG4 constant region comprising an S241P substitution (by Kabat numbering) and an L235E substitution (by EU numbering). - View Dependent Claims (6)
-
-
7. A pharmaceutical composition comprising a humanized antibody that binds complement C1s protein and comprises:
-
an antibody light chain variable region that comprises the amino acid sequence set forth in SEQ ID NO;
44;an antibody heavy chain variable region that comprises the amino acid sequence set forth in SEQ ID NO;
42; anda pharmaceutically-acceptable excipient. - View Dependent Claims (8, 9)
-
Specification